What's hot

View all perspectives
      #obesity causes a lot of diseases including #arthritis. How?
      ⬆️ IL-6
      ⬆️ leptin
      ⬆️ TNF-a
      @RheumNow #ACR24
      @

      sheila RHEUMarampa

      10 months ago
      #obesity causes a lot of diseases including #arthritis. How? ⬆️ IL-6 ⬆️ leptin ⬆️ TNF-a @RheumNow #ACR24 @rheumarhyme https://t.co/qeqTZUOEZy
      The Plants for Joints RA continuation made it to #ACR24!

      whole-food plant-based diet, exercise, sleep/stress Rx
      (added

      David Liew drdavidliew

      10 months ago
      The Plants for Joints RA continuation made it to #ACR24! whole-food plant-based diet, exercise, sleep/stress Rx (added on to usual RA care i.e. DMARDs) Gains made during program were sustained, can't undersell lifestyle as part of the overall picture! #ACR24 ABST0530 @RheumNow https://t.co/XSLIwYitpH https://t.co/RfiTX8Z6ff
      The TAPIR Trial on GPA shows higher (15.5%) relapse in the 0 mg prednisone arm vs. 4.2% in the 5 mg arm (OR 4.22), but d

      Antoni Chan MD (Prof) synovialjoints

      10 months ago
      The TAPIR Trial on GPA shows higher (15.5%) relapse in the 0 mg prednisone arm vs. 4.2% in the 5 mg arm (OR 4.22), but does not impact PROs. Key finding: benefit of 5 mg/day seen only in non-rituximab regimens (20% vs. 2.6%, OR 9.50). Abstr#0774 Plenary 1 @RheumNow #ACR24… https://t.co/5DjW5Zwh0J https://t.co/UnsVPzJfs6
      Want to lose weight naturally? Eat your veggies and protein first, and the carbs last— this reduces the post-prandial

      TheDaoIndex KDAO2011

      10 months ago
      Want to lose weight naturally? Eat your veggies and protein first, and the carbs last— this reduces the post-prandial glucose, insulin and raises GLP-1 - Dr Aronne #ACR24 @RheumNow https://t.co/cRVRzRTljT
      Dactylitis management in PsA:

      Acute: pain and swelling
      Chronic: painless swelling

      Broad ddx
      No role for LEF or SSZ

      #

      Adela Castro AdelaCastro222

      10 months ago
      Dactylitis management in PsA: Acute: pain and swelling Chronic: painless swelling Broad ddx No role for LEF or SSZ #ReviewCourse #ACR24 @RheumNow https://t.co/KZXv1UvhXn
      SELECT-GCA: Upa in GCAMerkelUpa 15 mg v 7.5 v PBO w slower GC taper70% new onset, 30% relapse. Few prev on IL6Primar

      Eric Dein ericdeinmd

      10 months ago

      SELECT-GCA: Upa in GCA Merkel Upa 15 mg v 7.5 v PBO w slower GC taper 70% new onset, 30% relapse. Few prev on IL6 Primary endpt: sustained remission at w52- UPA 15 mg beats PBO (p=0.0019) 34% relapse in UPA vs 60% PBO Less steroids, longer time to flare @RheumNow #ACR24 #ACRBest https://t.co/1OV2889Ny0

      Great summary of treatment choices in PsA:
      1. Identify domain involved
      2. Identify comorbidities/pt preferences
      3. Still

      Adela Castro AdelaCastro222

      10 months ago
      Great summary of treatment choices in PsA: 1. Identify domain involved 2. Identify comorbidities/pt preferences 3. Still unmet needs for ttx in inflammatory eye disease #ACR24 @rheumnow https://t.co/1WMnkDYvip
      Upadacitinib in GCA. Merkel et al. SELECT-GCA study. Sustained remission week 52 Upa (+26 week steroid) 46% vs PBO (+52

      Richard Conway RichardPAConway

      10 months ago
      Upadacitinib in GCA. Merkel et al. SELECT-GCA study. Sustained remission week 52 Upa (+26 week steroid) 46% vs PBO (+52 week steroid) 29%. Reduced flare rates with UPA (see picture). Similar to GiACTA results. @RheumNow #ACR24 Abstr#0770 https://t.co/fr75XK21L1 https://t.co/Hhax7po7vV
      search bar
      How Online Searches Reveal Patient Needs
      10 months ago
      Managing health conditions is rapidly evolving as patients increasingly turn to online resources for answers—over 65% search for health-related questions online. Our study analyzed Google search trends for rheumatic disease topics, offering a fascinating glimpse into how online search behavior can reveal patient needs and experiences. This approach, known as "infodemiology," tracks real-time Google Trends data to understand symptom- and
      What agent to pick after a TNFi has failed: another TNFi or a non-TNFi?
      Would a TNFi drug conc help (i.e. if low, increa

      David Liew drdavidliew

      10 months ago
      What agent to pick after a TNFi has failed: another TNFi or a non-TNFi? Would a TNFi drug conc help (i.e. if low, increased clearance due to secondary failure)? In this RCT @maartenskliniek, this TDM approach was no better than random selection. Argh #ACR24 ABST0533 @RheumNow https://t.co/3h8o4ARZG3
      Seronegative RA: sometimes there's an assumption that they'll eventually get a 'real' diagnosis

      at @MayoClinic, 85% of

      David Liew drdavidliew

      10 months ago
      Seronegative RA: sometimes there's an assumption that they'll eventually get a 'real' diagnosis at @MayoClinic, 85% of patients diagnosed with seronegative RA kept their diagnosis at 10 years. Usually, seroneg RA means seroneg RA! #ACR24 @MyasoedovaElena ABST0458 @RheumNow https://t.co/hErZVfs08k
      ❓What factors influence patient participation in rheumatology #ClinicalTrials?

      📌 Come to poster 0366 to find out!

      Mrinalini Dey DrMiniDey

      10 months ago
      ❓What factors influence patient participation in rheumatology #ClinicalTrials? 📌 Come to poster 0366 to find out! 👨🏻‍⚕️ @KKouranloo & @chriswincup report results from a UK study, showing marked differences by ethnicity & RMD @RheumNow Ab0366 #ACR24 https://t.co/kAqGJmNiPt
      Real-world data from @k_lauper's Jak-pot study (>9000 RA pt) on how quickly b/tsDMARDs work:
      JAKi, TNFi quicker than

      David Liew drdavidliew

      10 months ago
      Real-world data from @k_lauper's Jak-pot study (>9000 RA pt) on how quickly b/tsDMARDs work: JAKi, TNFi quicker than tocilizumab, abatacept Even though they all get to a similar place eventually, some get there quicker (but worth any safety tradeoffs?) #ACR24 ABST0501 @RheumNow https://t.co/YVpTBMe3gi
      Spatial Proteomics study for TEN

      Marked enrichment of type I and II interferon and STAT1 activation
      Pathways suggests b

      Eric Dein ericdeinmd

      10 months ago
      Spatial Proteomics study for TEN Marked enrichment of type I and II interferon and STAT1 activation Pathways suggests benefit for JAKi in this condition Clinical response in case photos, suggests benefit of pursuing clinical trial Year in Review #ACR24 Bridges @RheumNow https://t.co/K34lbnenRH
      Have you ever tried giving Semaglutide in addressing weight loss among your patients with #osteoarthritis and #obesity?

      sheila RHEUMarampa

      10 months ago
      Have you ever tried giving Semaglutide in addressing weight loss among your patients with #osteoarthritis and #obesity? @RheumNow #ACR
      How well do you know this week's rheumatology news?
      Take the rheumIQ quiz
      Take the RheumIQ Quiz

      Podcasts

      • ACR24 IL-17 Topic Panel Advancing Care with IL-17 Pathway Insights
      • ACR24 JAK TYK Topic Panel
      • RheumNow Day 1 Recap ACR Convergence 2024 Highlights

      Catch up on Conference Podcasts

      ×